(23) found that HMGA2 overexpression was significantly associated with a decrease in overall survival (OS) in melanoma patients, suggesting that high expression of HMGA2 was associated with poor prognosis in patients with malignant melanoma. This evidence concerns the gene HMGA2 and melanoma.